Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: A cross-sectional study - PubMed (original) (raw)

doi: 10.1016/j.jinf.2020.12.002. Epub 2020 Dec 4.

Dorsaf Slama 2, Thomas De Broucker 3, Marina Karmochkine 2, Juliette Pavie 2, Emmanuel Sorbets 4, Nicolas Etienne 5, Dominique Batisse 2, Gabriela Spiridon 2, Valérie Le Baut 2, Jean-François Meritet 6, Eric Pichard 2, Florence Canouï-Poitrine 7; APHP COVID-19 research collaboration

Affiliations

Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: A cross-sectional study

Dominique Salmon-Ceron et al. J Infect. 2021 Feb.

No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest All the authors have read and agreed with the paper's content. No authors have financial or personal conflicts. Neither the work nor any part of its essential substance, tables or figures have been or will be published or submitted to another scientific journal or are being considered for publication elsewhere.

Figures

Fig. 1

Fig. 1

Distribution of the symptoms of the acute COVID-19 phase versus those of the prolonged -COVID phase in 70 patients presenting with persistent and/or remerging late symptoms of COVID after a confirmed SARS-CoV-2 infection. Legend of the figure: 1. Sensory disturbances include balance disorders, tingling, burning sensations and neurogenic pains. 2. Mucco cutaneo signs include acrocyanosis, rash, flash face, eczema, tongue swelling, pruritus, vascular inflammation, spontaneous ecchymosis. 3. Other cardiological signs include sudden malaise, desaturation. 4. Cognitive psycho disorders include memory, humor or attention disturbances and disorientation. 5. Other neurological signs include or swallowing disorders, thermal dysregulation and speech.

Similar articles

Cited by

References

    1. Chen J., Qi T., Liu L., Ling Y., Qian Z., Li T. Clinical progression of patients with COVID-19 in Shanghai, China. J Infect. 2020;80(5):e1–e6. doi: 10.1016/j.jinf.2020.03.004. Epub 2020 Mar 19PMID: 32171869. - DOI - PMC - PubMed
    1. Carfì A., Bernabei R., Landi F., Gemelli Against COVID-19 Post-Acute Care Study Group. Carfì A. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–605. doi: 10.1001/jama.2020.12603. PMID: 32644129. - DOI - PMC - PubMed
    1. Kang H., Wang Y., Tong Z., Liu X. Retest positive for SARS-CoV-2 RNA of “Recovered” patients with COVID-19: persistence, sampling issues, or re-infection? JMV. 2020 doi: 10.1002/jmv.26114. - DOI - PMC - PubMed
    1. Goussef M., Penot P., Gallay L., Batisse D., Bouiller K., Collarino R. Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound? J Infect. 2020 S0163-4453(20)30454-0. - PMC - PubMed
    1. Hamming I., Timens W., Bulthuis M., Lely A., Navis G., van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004;203:631–637. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources